COVID-19 and Cardiovascular Health Among Patients with Cancer.
Nicolas L PalaskasEfstratios KoutroumpakisAnita DeswalPublished in: Current cardiology reports (2020)
Patients more susceptible to COVID-19 with increased severity of disease include those with cancer and cardiovascular comorbidities. In addition, the cardiovascular complications of COVID-19 including acute myocardial injury, thromboembolism, cardiomyopathy, myocarditis, and pericardial disease overlap with many of those encountered during cancer treatment. Despite the absence of large studies of patients with both cancer and cardiovascular disease, the incidence of cardiovascular complications in cancer patients with COVID-19 is expected to be high. This has implications for cardiac monitoring, chemotherapy administration, and the diagnosis and treatment of cardiovascular disease during COVID-19.
Keyphrases
- cardiovascular disease
- coronavirus disease
- papillary thyroid
- sars cov
- squamous cell
- risk factors
- type diabetes
- heart failure
- lymph node metastasis
- left ventricular
- intensive care unit
- childhood cancer
- metabolic syndrome
- radiation therapy
- cardiovascular risk factors
- young adults
- acute respiratory distress syndrome
- respiratory failure
- locally advanced
- chemotherapy induced